Related Experiment Video
Updated: Jun 19, 2026

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
Published on: September 10, 2016
State of the Art of Probiotic Use in Neonatal Intensive Care Units in French-Speaking European Countries
Amélie Blanchetière1, Charles Dolladille2, Isabelle Goyer3
1Department of Neonatology, University Hospital of Caen, 14000 Caen, France.
Insights
Probiotic use in European neonatal intensive care units (NICUs) is low and inconsistent. Key barriers include lack of recommendations, unclear strain selection, and safety concerns, necessitating further research for optimal preterm infant care.
Area of Science:
- Neonatal Medicine
- Microbiology
- Clinical Pharmacy
Background:
- Necrotizing enterocolitis (NEC) is a significant concern in preterm infants.
- Probiotics show promise in reducing NEC incidence, but their routine use in neonatal intensive care units (NICUs) is debated.
- Evidence supporting probiotic efficacy necessitates understanding current clinical practice and barriers.
Purpose of the Study:
- To determine the rate of probiotic use in European NICUs.
- To compare current probiotic administration protocols.
- To identify barriers and concerns hindering widespread probiotic adoption.
Main Methods:
- An online survey was emailed to European NICUs from October 2020 to June 2021.
- The survey collected data on probiotic usage frequency, administration protocols, and reasons for non-utilization.
- Response rates from France (85%) and Switzerland (89%) were notably high.
Main Results:
- Routine probiotic use varied significantly, with 21% in French NICUs and 100% in Swiss NICUs reporting regular administration.
- Substantial heterogeneity was observed in probiotic strains, administration methods, and treatment durations.
- Primary obstacles included absence of official recommendations, lack of consensus on strain selection, and concerns about safety and evidence.
Conclusions:
- Routine probiotic administration in European NICUs is currently low and characterized by protocol variability.
- Further clinical trials are essential to establish optimal probiotic treatment strategies and confirm safety for preterm infants.
- Addressing identified barriers is crucial for increasing consistent and evidence-based probiotic use.
Abstract:
The effectiveness of probiotics in reducing the incidence of necrotizing enterocolitis has been supported by a very large number of studies. However, the utilization of probiotics in preterm infants remains a topic of debate. This study aims to assess the rate of probiotic use in European neonatal intensive care units (NICUs), compare administration protocols, and identify barriers and concerns associated with probiotic use. An online questionnaire was distributed via email to European NICUs between October 2020 and June 2021. Different questions related to the frequency of probiotic use were proposed. Data on probiotic administration protocols and reasons for non-utilization were collected. The majority of responses were from France and Switzerland, with response rates of 85% and 89%, respectively. A total of 21% of French NICUs and 100% of Swiss NICUs reported routine probiotic use. There was significant heterogeneity in probiotic administration protocols, including variations in probiotic strains, administration, and treatment duration. The main obstacles to routine probiotic use were the absence of recommendations, lack of consensus on strain selection, insufficient scientific evidence, and concerns regarding potential adverse effects. The rate of routine probiotic administration remains low in European NICUs, with heterogeneity among protocols. Further trials are necessary to elucidate optimal treatment modalities and ensure safety of administration.
Related Concept Videos
Differential Staining Technique
Special Staining Techniques
Key Techniques in Microbiology
Development of Human Microbiota
Development of the Oral Microbiota

